Wealth Enhancement Advisory Services LLC Purchases 6,986 Shares of GE HealthCare Technologies Inc. $GEHC

Wealth Enhancement Advisory Services LLC increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 13.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 59,212 shares of the company’s stock after buying an additional 6,986 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in GE HealthCare Technologies were worth $4,411,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Dodge & Cox grew its position in shares of GE HealthCare Technologies by 42.1% in the second quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock valued at $1,745,678,000 after purchasing an additional 6,982,441 shares during the last quarter. Norges Bank acquired a new stake in GE HealthCare Technologies in the 2nd quarter valued at approximately $468,120,000. Holocene Advisors LP lifted its holdings in shares of GE HealthCare Technologies by 178.5% during the second quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock worth $298,306,000 after buying an additional 2,581,522 shares during the last quarter. Menora Mivtachim Holdings LTD. bought a new stake in shares of GE HealthCare Technologies in the second quarter valued at approximately $80,755,000. Finally, Balyasny Asset Management L.P. acquired a new stake in shares of GE HealthCare Technologies in the second quarter worth $58,388,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ:GEHC opened at $80.27 on Tuesday. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95. The business’s fifty day moving average price is $82.17 and its two-hundred day moving average price is $77.26. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The stock has a market capitalization of $36.56 billion, a price-to-earnings ratio of 16.58, a price-to-earnings-growth ratio of 2.41 and a beta of 1.08.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, beating the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The company had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $5.07 billion. During the same quarter in the previous year, the company earned $1.14 EPS. The firm’s revenue for the quarter was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s payout ratio is presently 2.89%.

Wall Street Analysts Forecast Growth

GEHC has been the subject of several research analyst reports. The Goldman Sachs Group reiterated a “buy” rating and set a $98.00 target price on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Barclays assumed coverage on GE HealthCare Technologies in a research report on Monday, October 13th. They set an “equal weight” rating and a $86.00 target price on the stock. Stifel Nicolaus boosted their price target on GE HealthCare Technologies from $90.00 to $95.00 and gave the company a “buy” rating in a research note on Wednesday, January 7th. BTIG Research reiterated a “buy” rating and issued a $87.00 price objective on shares of GE HealthCare Technologies in a research report on Friday, November 21st. Finally, Bank of America lifted their price objective on GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a report on Monday, January 5th. Seven equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $89.83.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.